๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum immunoglobulin levels following allogeneic bone marrow transplantation

โœ Scribed by Perreault, Claude ;Giasson, Marc ;Gyger, Martin ;Belanger, Robert ;David, Michele ;Bonny, Yvette ;Boileau, Jacques ;Barcelo, Raymond ;Moquin, Jean Pierre


Publisher
Springer-Verlag
Year
1985
Weight
361 KB
Volume
51
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

โœฆ Synopsis


In order to study the posttransplant evolution of serum immunoglobulin levels, we measured serum IgG, IgA and IgM levels in 50 recipients of allogeneic bone marrow before transplantation and at different intervals thereafter (days 39, 120, 365 and 730). IgG and IgM levels were depressed for 1 year and IgA levels for 2 years posttransplant. Immunoglobulin deficiency was more severe and prolonged in patients with graft versus-host-disease. Hypogammaglobulinemia may contribute to the frequent infections observed in these patients, especially those with chronic graft-versus-host disease.


๐Ÿ“œ SIMILAR VOLUMES


Hyperammonemia following allogeneic bone
โœ Nielson Tse; Stephen Cederbaum; John A. Glaspy ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 181 KB ๐Ÿ‘ 1 views

Hyperammonemia is a rare and serious complication of intensive cytotoxic chemotherapy. We report the case of a patient who developed profound idiopathic hyperammonemia following bone marrow transplantation for chronic myelogenous leukemia. Despite rapid institution of hemodialysis, sodium benzoate,

Cyclosporin associated demyelination fol
โœ Dr. M. J. Lind; L. McWilliam; J. Jip; J. H. Scarffe; G. R. Morgenstern; J. Chang ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 252 KB

Neurological complications associated with cyclosporin administration are well documented. However their histopathological basis are ill-understood. We describe below a case of demyelination following cyclosporin administration to a patient following allogeneic bone marrow transplantation.

Neutropenias following allogeneic bone m
โœ Khouri, Issa F.; Ippoliti, Cindy; Gajewski, James; Przepiorka, Donna; Champlin, ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 249 KB ๐Ÿ‘ 2 views

Cytopenias following bone marrow transplantation may be severe and life-threatening. These have been described post-allogeneic Klumpp, 1991 : Bone Marrow Transplant 8:159-171. or post-autologous bone marrow transplants

Graft versus host disease following allo
โœ Nelson J Chao ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 781 KB

Graft versus host disease is a major barrier in allogeneic bone marrow transplantation. The associated morbidity and mortality need to be understood and prevented if possible, as the potential indications for bone marrow transplantation continue to broaden. Areas of investigation include the cellula

Extra-medullary relapse of leukemia foll
โœ W. Y. Au; Y. L. Kwong; A. K. W. Lie; S. K. Ma; R. Liang ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 208 KB ๐Ÿ‘ 2 views

The curative effect of allogeneic bone marrow transplantation (BMT) for acute and chronic leukemia is attributed to the intensive conditioning chemotherapy with or without radiotherapy, as well as an immune-mediated graft versus leukemia (GVL) effect. A different pattern of relapse has been observed